MOXYLAN 50MG TABLETS BROAD SPECTRUM ANTIBIOTIC Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

moxylan 50mg tablets broad spectrum antibiotic

jurox pty limited - amoxycillin as amoxycillin trihydrate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 50.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

A.F.S AMOXCILIN SOLUBLE AMOXYCILLIN TRIHYDRATE POWDER Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

a.f.s amoxcilin soluble amoxycillin trihydrate powder

parafarm pty ltd - amoxycillin as amoxycillin trihydrate - oral powder, pre-mix - amoxycillin as amoxycillin trihydrate antibiotic active 840.0 mg/g - antibiotic & related - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

Fungentin Malta - English - Medicines Authority

fungentin

elpen pharmaceutical co. inc. 95 marathonos ave., 190 09 pikermi, attica, greece - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 500 mg clavulanic acid 125 mg - antibacterials for systemic use

Fungentin Malta - English - Medicines Authority

fungentin

elpen pharmaceutical co. inc. 95 marathonos ave., 190 09 pikermi, attica, greece - amoxicillin, clavulanic acid - powder for oral suspension - amoxicillin 250 mg/5ml clavulanic acid 62.5 mg/5ml - antibacterials for systemic use

Noroclav Injection New Zealand - English - Ministry for Primary Industries

noroclav injection

norbrook nz limited - clavulanic acid present as potassium clavulanate; amoxicillin - clavulanic acid present as potassium clavulanate 35 g/litre; amoxicillin 140 g/litre - antibiotic

Juroclav 250 Broad Spectrum Antibiotic Tablets New Zealand - English - Ministry for Primary Industries

juroclav 250 broad spectrum antibiotic tablets

zoetis new zealand limited - clavulanic acid present as potassium clavulanate; amoxicillin present as amoxicillin trihydrate - clavulanic acid present as potassium clavulanate 58.82 g/kg; amoxicillin present as amoxicillin trihydrate 235.2 g/kg - antibiotic

ALPHACLAV DUO FORTE VIATRIS 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

alphaclav duo forte viatris 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablets blister pack

alphapharm pty ltd - amoxicillin trihydrate, quantity: 1006.25 mg; potassium clavulanate, quantity: 148.875 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; propylene glycol; croscarmellose sodium; ethylcellulose; purified talc; isopropyl alcohol; magnesium stearate; hypromellose; dichloromethane; titanium dioxide; hyprolose; industrial methylated spirit - alphaclav duo forte viatris 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (uncomplicated and complicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infection,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate.,the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets should not require the addition of another antibiotic due to the amoxicillin content of these products.